Skip to Main Content

Paper Details

Secretory leukocyte protease inhibitor and risk of heart failure in the Multi-Ethnic Study of Atherosclerosis.
Sci Rep
3
2023
Atherosclerosis, HF, HFpEF, HFrEF, SLPI, Secretory leukocyte protease inhibitor, circulating SLPI protein quantitative trait loci, heart failure, pQTLs, participants, serine, serine protease, serum SLPI
Author NameAffiliation
Konrad Teodor SawickiNorthwestern University Feinberg School of Medicine
Konrad Teodor SawickiCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine
Konrad Teodor SawickiNorthwestern University Feinberg School of Medicine
Suzette J BielinskiMayo Clinic
Suzette J BielinskiMayo Clinic
Nicholas B LarsonMayo Clinic
Donald M Lloyd-JonesNorthwestern University Feinberg School of Medicine
Donald M Lloyd-JonesNorthwestern University Feinberg School of Medicine
Bruce M PsatyCardiovascular Health Research Unit, University of Washington
Kent D TaylorInstitute for Translational Genomics, The Lundquist Institute for Biomedical Innovation at Harbor-university of california los angeles Medical Center
Laura J Rasmussen-TorvikNorthwestern University Feinberg School of Medicine
Laura J Rasmussen-TorvikNorthwestern University Feinberg School of Medicine
  • 1 - 12

Datasets

Release 1.2